ArticleAmerican journal of hematology2015

Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL).

Kami Maddocks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.